Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Oncology|May 5, 2012
A Phase II study of clinical outcomes of 3-week cycles of irinotecan and S-1 in patients with previously untreated metastatic colorectal cancer: influence of the UGT1A1 and CYP2A6 polymorphisms on clinical activityYoon Hee Choi, Tae Won Kim, Kyu-Pyo Kim, et al.
Journal of Cellular Biochemistry|November 12, 2010
Transforming growth factor-β induces epithelial to mesenchymal transition and suppresses the proliferation and transdifferentiation of cultured human pancreatic duct cellsJeong-Ah Shin, Oak-Kee Hong, Hye-Jung Lee, et al.
BMJ Open|July 26, 2015
A questionnaire survey exploring healthcare professionals' attitudes towards teamwork and safety in acute care areas in South KoreaSung Eun Kim, Chan Woong Kim, Sang Jin Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2022
A Phase 2 Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumors (KCSG LU17-21)Hyun Ae Jung, Miso Kim, Hae Su Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2019
Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)Jang Ho Cho, Sung Hee Lim, Ho Jung An, et al.
Diabetes Care|November 30, 2006
Long-term effect of the Internet-based glucose monitoring system on HbA1c reduction and glucose stability: a 30-month follow-up study for diabetes management with a ubiquitous medical care systemJae-Hyoung Cho, Sang-Ah Chang, Hyuk-Sang Kwon, et al.
International Journal of Oncology|January 10, 2014
Combination of AG490, a Jak2 inhibitor, and methylsulfonylmethane synergistically suppresses bladder tumor growth via the Jak2/STAT3 pathwayYoun Hee Joung, Yoon Mi Na, Young Bum Yoo, et al.
Cancer Chemotherapy and Pharmacology|August 29, 2012
A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02Yoon Hee Choi, Sang Cheul Oh, Jun Suk Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2023
Structural insights into the multifunctionality of rabies virus P3 proteinAshish Sethi, Stephen M Rawlinson, Abhinav Dubey, et al.
Cancer Research and Treatment|December 27, 2024
Clinical Impact of TP53 Mutations in Patients with Head and Neck Cancer Who Were Treated with Targeted Therapies or ImmunotherapyEun Joo Kang, Shinwon Hwang, Yun-Gyoo Lee, et al.
Pageof 15